Collaboration Explores Therapies for Autoimmune Diseases

Collaboration Explores Therapies for Autoimmune Diseases

303241

Collaboration Explores Therapies for Autoimmune Diseases

Cytocom has joined forces with La Jolla Institute for Immunology (LJI) to discover and develop new immune-modulating therapies targeting toll-like receptors (TLRs) for autoimmune diseases such as multiple sclerosis (MS), cancer, and infectious and chronic inflammatory conditions. TLRs are an important family of protein receptors found at the surface of immune cells and others; they play a critical role in activating the first line of defense against microbes. As such, they are key to fighting disease…

You must be logged in to read/download the full post.